tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
CRSP
Crispr Therapeutics AG
Stock Analysis
Analyst Forecasts
Technical Analysis
New
Chart
Earnings
Dividends
Financials
News & Insights
Insider Trading
Crowd Wisdom
Hedge Funds
Similar Stocks
Blogger Opinion
Risk Analysis
reports

Crispr Therapeutics AG (CRSP) Income Statement

5,896 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q1 2023), Crispr Therapeutics AG's total revenue was $100.00M, an increase of 56079.78% from the same quarter last year. In Q1, Crispr Therapeutics AG's net income was $-53.06M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 100.26M$ 436.00K$ 913.08M$ 719.00K$ 289.59M$ 3.12M
Cost of Revenue
$ 79.60M$ 110.25M----
Gross Profit
$ 20.65M$ -109.81M----
Operating Expense
$ 582.33M$ 563.35M$ 539.55M$ 355.15M$ 242.85M$ 162.07M
Operating Income
$ -561.68M$ -673.16M$ 373.53M$ -354.44M$ 46.74M$ -158.94M
Net Non Operating Interest Income Expense
-----$ 0.00
Other Income Expense
$ 9.56M$ 22.66M$ 6.00M$ 6.38M$ 20.57M$ -5.49M
Pretax Income
$ -526.64M$ -650.50M$ 379.53M$ -348.06M$ 67.31M$ -164.43M
Tax Provision
$ -2.61M$ -325.00K$ 1.87M$ 809.00K$ 448.00K$ 553.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -524.02M$ -650.17M$ 377.66M$ -348.87M$ 66.86M$ -164.98M
Basic EPS
$ -6.72$ -8.36$ 4.97$ -5.29$ 1.23$ -3.44
Diluted EPS
$ -6.72$ -8.36$ 4.70$ -5.29$ 1.17$ -3.44
Basic Average Shares
$ 312.55M$ 77.75M$ 75.95M$ 65.95M$ 56.93M$ 47.96M
Diluted Average Shares
$ 312.55M$ 77.75M$ 80.39M$ 65.95M$ 56.93M$ 47.96M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 661.93M$ 673.60M$ 539.55M$ 355.15M$ 242.85M$ 162.07M
Net Income From Continuing And Discontinued Operation
$ -524.02M$ -650.17M$ 377.66M$ -348.87M$ 66.86M$ -164.98M
Normalized Income
$ -470.96M$ -650.17M$ 377.66M$ -348.87M$ 66.86M$ -164.98M
Interest Expense
-----$ 0.00
EBIT
$ -548.93M$ -673.16M$ 373.53M$ -354.44M$ 46.74M$ -158.94M
EBITDA
$ -525.75M$ -648.99M$ 391.48M$ -345.25M$ 51.47M$ -155.42M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing